Dr. Wesley Kyle Padilla is a Dallas, Oregon based male chiropractor who is specialized as General Chiropractor. Active license number of Dr. Wesley Kyle Padilla as General Chiropractor is 6309 in Oregon. Dr. Wesley Kyle Padilla is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Wesley Kyle Padilla speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
DC
Gender:
Male
Practice Address:
289 E Ellendale Ave Ste 701, Dallas, Oregon, 97338-1559
Phone:
503-967-8568
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1992498323
NPI Enumeration Date:
31 May, 2023
NPI Last Update On:
28 Apr, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Wesley Kyle Padilla are as mentioned below.
License Number
Specialization
State
Status
6309
Chiropractor
Oregon
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
289 E Ellendale Ave Ste 701, Dallas, Oregon
Zip:
97338-1559
Phone Number:
503-967-8568
Fax Number:
--
Patients can reach Dr. Wesley Kyle Padilla at 289 E Ellendale Ave Ste 701, Dallas, Oregon or can call to book an appointment on 503-967-8568. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.